TY - JOUR
T1 - Air pollution exposure and cardiometabolic risk
AU - Rajagopalan, Sanjay
AU - Brook, Robert D.
AU - Salerno, Pedro R.V.O.
AU - Bourges-Sevenier, Brendan
AU - Landrigan, Philip
AU - Nieuwenhuijsen, Mark J.
AU - Munzel, Thomas
AU - Deo, Salil V.
AU - Al-Kindi, Sadeer
N1 - Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
PY - 2024/3
Y1 - 2024/3
N2 - The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with a diameter of 2·5 μm or less (PM2·5). With 99% of the global population residing in areas where air pollution levels are above current WHO air quality guidelines, and increasing concern in regard to the common drivers of air pollution and climate change, there is a compelling need to understand the connection between air pollution and cardiometabolic disease, and pathways to address this preventable risk factor. This Review provides an up to date summary of the epidemiological evidence and mechanistic underpinnings linking air pollution with cardiometabolic risk. We also outline approaches to improve awareness, and discuss personal-level, community, governmental, and policy interventions to help mitigate the growing global public health risk of air pollution exposure.
AB - The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with a diameter of 2·5 μm or less (PM2·5). With 99% of the global population residing in areas where air pollution levels are above current WHO air quality guidelines, and increasing concern in regard to the common drivers of air pollution and climate change, there is a compelling need to understand the connection between air pollution and cardiometabolic disease, and pathways to address this preventable risk factor. This Review provides an up to date summary of the epidemiological evidence and mechanistic underpinnings linking air pollution with cardiometabolic risk. We also outline approaches to improve awareness, and discuss personal-level, community, governmental, and policy interventions to help mitigate the growing global public health risk of air pollution exposure.
KW - Humans
KW - Diabetes Mellitus, Type 2/epidemiology
KW - Air Pollution/adverse effects
KW - Climate Change
KW - Public Health
KW - Cardiovascular Diseases/epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85184049449&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85184049449&partnerID=8YFLogxK
U2 - 10.1016/S2213-8587(23)00361-3
DO - 10.1016/S2213-8587(23)00361-3
M3 - Review article
C2 - 38310921
AN - SCOPUS:85184049449
SN - 2213-8587
VL - 12
SP - 196
EP - 208
JO - The Lancet Diabetes and Endocrinology
JF - The Lancet Diabetes and Endocrinology
IS - 3
ER -